U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Search AHRQ

For an exact phrase match, enclose search terms in double quotes.

Go to Advanced Search
Go to Basic Search

Results

Total Results: 2,078 records

Showing results for "drugs".

  1. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/12_pregnancy_potential_high_impact_2012-12-11.pdf
    January 01, 2012 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … In the health care sector, horizon scanning pertains to identifying new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … The table below lists the three topics for which (1) preliminary phase III data were available for drugs

  2. Opioid Treatments for Chronic Pain | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/products/opioids-chronic-pain/protocol
    February 27, 2019 - action of opioids used (e.g., pure opioid agonists, partial opioid agonists such as buprenorphine or drugs … there differences between pure opioid agonists and partial opioid agonists such as buprenorphine or drugs … Intravenous or intramuscular administration of opioids Nonopioid therapies (pharmacologic [antiepileptic drugs … , benzodiazepines, nonsteroidal antiinflammatory drugs, skeletal muscle relaxants, serotonin norepinephrine

  3. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1406.pdf
    February 01, 2015 - health care sector, horizon scanning pertains to identification of new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the … targeting pathways and processes hypothesized to underlie AD-related cognitive decline, neuroprotective pharmaceuticals … CNS Drugs. 2013 Jul;27(7):505-14.

  4. Comparative Effectiveness of First and Second Generation Antipsychotics in the Pediatric and Young Adult Populations | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/products/antipsychotics-children/research-protocol
    June 04, 2010 - We were asked to study the use of these drugs for the following conditions: 1) pervasive developmental … Intervention drugs of interest The intervention drug must be an FDA-approved first or second generation … These drugs include: aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine … Comparison drugs of interest The comparison drug must be any other FDA-approved first or second generation … co-morbidities, use of concurrent standard medical therapies), details of the intervention and comparator (drugs

  5. Identification and Treatment of Post-Acute Coronary Syndrome (ACS) Depression: A Systematic Review | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/products/acs-depression/research-protocol
    August 31, 2016 - Appendixes Appendix A: FDA Status and Warnings for Drugs Included in this Review Table A1. … Vintage Pharmaceuticals,LLC, Huntsville, AL, 2006. Amitriptyline: Drug Information. … Teva Pharmaceuticals USA, Inc. (per FDA), Horsham, PA, 2014. Protriptyline: Drug Information.

  6. Clopidogrel After Drug-Eluting Stent Implantation: Is Current Practice Sufficient? | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/products/stent-clopidogrel-practice/research
    March 31, 2009 - Clopidogrel After Drug-Eluting Stent Implantation: Is Current Practice Sufficient? Research Report Archived March 31, 2009 Download Main Document PDF 8.2 MB Note : This report is greater than 5 years old. Findings may be used for research purposes but should not be considered current. Author Affiliat…

  7. Antipsychotics-Children Research-Protocol (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/antipsychotics-children_research-protocol.pdf
    June 04, 2010 - We were asked to study the use of these drugs for the following conditions: 1) pervasive developmental … Intervention drugs of interest The intervention drug must be an FDA-approved first or second generation … These drugs include: aripiprazole, asenapine, clozapine, iloperidone, olanzapine, paliperidone, quetiapine … Comparison drugs of interest http://www.effectivehealthcare.ahrq.gov/� Source: www.effectivehealthcare.ahrq.gov … co-morbidities, use of concurrent standard medical therapies), details of the intervention and comparator (drugs

  8. Management of Suspected Opioid Overdose with Naloxone Guidelines by Emergency Medical Services Personnel | Effective Health Care (EHC) Program

    effectivehealthcare.ahrq.gov/products/emt-naloxon/research-protocol
    November 30, 2016 - , race, type of opioid involved in overdose, dose of opioid involved in overdose, presence of other drugs … , race, type of opioid involved in overdose, dose of opioid involved in overdose, presence of other drugs

  9. App-F2-Surv-Report-2-Nonopioid-Pharmacol-Chronic-Pain (xls file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f2-surv-report-2-nonopioid-pharmacol-chronic-pain.xlsx
    September 20, 2022 - TCA_PCT Table F-2a. Harms of tricyclic antidepressants versus placebo Author, Year Quality Pain Population Drug Class Drug Assessment Time (Wk) Time Category WAE: n WAE: N SAE: n SAE: N Cardiac Rhythm Abnormalities: Specific AE Cardiac Rhythm Abnormalities: n Cardiac Rhythm Abnormalities: N N Randomized Cognitive Eff…

  10. EPC Program 2019 Year in Review (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/epc-year-in-review-2019.pdf
    January 01, 2019 - EPC Program 2019 Year in Review Evidence-based Practice Center Program 2019 Year in Review EPC Mission: Transform healthcare by increasing the quality, availability, and use of evidence via scientifically rigorous and unbiased analysis of evidence Completed Research 11 Research Reports 8 Methods Reports 8 Manusc…

  11. Fibromyalgia Executive (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/fibromyalgia_executive.pdf
    January 01, 2015 - Treatment components may include drugs, exercise programs, cognitive behavioral therapy (CBT), patient … In addition, numerous drugs approved for other conditions are currently used off label in patients … Pharmacolgic, nonpharmocologic, or multimodal treatments Adverse effects of drugs or interventions … We excluded studies of drugs not FDA approved in the United States for any condition; studies that … Subgroup Outcomes In this section, we first examine the effect of drugs on various subgroups and then

  12. AHRQ's Evidence-based Practice Center Division Annual Report 2019: Solving the Puzzle for Evidence-Based Decision Making (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-year-in-review-2019.pdf
    January 01, 2019 - AHRQ's Evidence-based Practice Center Division Annual Report 2019: Solving the Puzzle for Evidence-Based Decision Making AHRQ’s Evidence-based Practice Center Divison Annual Report 2019 Solving the Puzzle for Evidence-Based Decision Making e Evidence-based Practice Center Program 2019 Year in Review EPC Missi…

  13. Revised Protocol - Opioids 12 13 13[1] (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-pain-opioid-treatment_research-protocol.pdf
    December 19, 2013 - http://www.fda.gov/downloads/Drugs/DrugSafet y/InformationbyDrugClass/UCM348818.pdf. 29. … www.effectivehealthcare.ahrq.gov http://www.uspreventiveservicestaskforce.org/us http://www.fda.gov/downloads/Drugs

  14. PEPTIC ULCER #11 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1312.pdf
    December 01, 2013 - Drugs. 2011 Dec 24;71(18):2381-9. PMID: 22117130 7. … Bedminster (NJ): NPS Pharmaceuticals, Inc.; 2012 Dec [accessed 2013 Jun 5]. [19 p]. … Bedminster (NJ): NPS Pharmaceuticals, Inc.; 2011 May 12 [accessed 2011 Jul 15]. [2 p]. … Bedminster (NJ): NPS Pharmaceuticals, Inc.; 2011 Oct 31 [accessed 2011 Nov 11]. [4 p]. … Bedminster (NJ): NPS Pharmaceuticals, Inc.; 2012 Oct 16 [accessed 2012 Oct 16]. [3 p].

  15. Updating Current Effectiveness Reviews (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-assessment-research-updates_research.pdf
    September 15, 2008 - conduct and support research on the comparative outcomes, clinical effectiveness, and appropriateness of pharmaceuticals … support research with a focus on outcomes, comparative clinical effectiveness, and appropriateness of pharmaceuticals … MedWatch database and the Canadian Health Services (CHS) pharmaceutical database for any reports about drugs

  16. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1306.pdf
    June 11, 2013 - Coordinating Council for Comparative Effectiveness Research, AHRQ is interested in innovations in drugs … In the health care sector, horizon scanning pertains to identifying new (and new uses of existing) pharmaceuticals … For purposes of horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures … Information is compiled for expert comment on topics at a granular level (i.e., similar drugs in the

  17. Management of suspected opioid overdose with Naloxone by Emergency Medical Services personnel (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/emt-naloxon_research-protocol.pdf
    November 29, 2016 - race, type of opioid involved in overdose, dose of opioid involved in overdose, presence of other drugs … race, type of opioid involved in overdose, dose of opioid involved in overdose, presence of other drugs

  18. Survey of Medicare Part D Plans’ Medication Therapy Management Programs (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/pdf/medication-therapy-management-1_research-2007.pdf
    January 01, 2007 - Survey of Medicare Part D Plans’ Medication Therapy Management Programs Effective Health Care Research Reports Number 1 Survey of Medicare Part D Plans’ Medication Therapy Management Programs Daniel R. Touchette, Pharm.D., M.A. Anne L. Burns, R.Ph. Marcie A. Bough, Pharm.D. Juan C. Blackburn, M.D., M.B.…

  19. Layout 1 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/related_files/ace-inhibitor-arb-update_executive.pdf
    June 01, 2011 - Currently, three classes of drugs that interact with this system are used to inhibit the effects of angiotensin … (2) Relative persistence with drug therapy across the different classes of drugs.

  20. Ch 1-User-Guide-To-Ocer 130129 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/ch_1-user-guide-to-ocer_130129.pdf
    August 13, 2012 - Coverage Which bisphosphonate drugs should be included on a drug formulary? … management What should a health plan do to minimize the risks associated with use of bisphosphonate drugs
SHARE:
Facebook Twitter Print Facebook Share

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site:

View results from all sites